[ad_1] Recently co-authored: Real-world outcomes (~50,000 eyes) of anti-VEGF therapy for AMD – only 1 letter gained at 1 year, meaningfully worse than clinical trials. Download: https://lnkd.in/efPCAD5 https://www.sciencedirect.com/science/article/pii/S2468653019302805?via%3Dihub Visual Acuity Outcomes and Anti–Vascular Endothelial Growth Factor Therapy Intensity in Neovascular Age-Related Macular Degeneration Patients: A …

[ad_1] The 2017 U.S. FDA approval of the first gene therapy for a genetic disease launched a promising new cycle of innovation in ophthalmic therapies…. https://www.youtube.com/watch?v=FNUUnJgWHUY&t= Watch the Advancements in Genetic and Regenerative Therapies panel at Ophthalmology Innovation Summit @ ASRS 2019. REGISTER for our …